Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG treatment for gut health in adults with cystic fibrosis
NL-OMON48606Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of macrogol + potassium chloride + sodium chloride + sodium bicarbonate in cystic fibrosis (CF), sponsored by University Medical Center Groningen. Primary endpoint: Change in plasma fibroblast growth factor 19. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
macrogol + potassium chloride + sodium chloride + sodium bicarbonate
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON48606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48606.